Abstract
Intracolonic (i.col.) administration of the PAR2-activating peptide (PAR2AP) SLIGRL-NH2 slowly develops visceral hypersensitivity to i.col. capsaicin in ddY mice. Thus, we further analyzed roles of PAR2 in colonic hypersensitivity, using the novel potent PAR2AP, 2-furoyl-LIGRL-NH2 and PAR2-knockout (KO) mice. In ddY mice, i.col. 2-furoyl-LIGRL-NH2 produced delayed (6 h later) facilitation of capsaicin-evoked visceral nociception, an effect being much more potent than SLIGRL-NH2. Such effects were mimicked by i.col. trypsin. In wild-type (WT), but not PAR2-KO, mice of C57BL/6 background, i.col. PAR2 agonists caused delayed facilitation of sensitivity to capsaicin. The PAR2-triggered visceral hypersensitivity was abolished by a bradykinin B2 receptor antagonist, HOE-140. Our data thus provide ultimate evidence for role of PAR2 in colonic hypersensitivity, and suggest involvement of the bradykinin-B2 pathway.
References
Jun 1, 1996·British Journal of Pharmacology·M SaifeddineM D Hollenberg
Jan 23, 1999·The Journal of Clinical Investigation·T D NguyenN W Bunnett
Feb 25, 1999·Gastroenterology·T M CocksS Selemidis
Apr 26, 2000·British Journal of Pharmacology·A KawabataM D Hollenberg
Mar 30, 2001·Neuroreport·A KawabataH Nishikawa
May 30, 2001·Pain·J M LairdF Cervero
Jun 8, 2001·The Journal of Clinical Investigation·A KawabataK Kakehi
Aug 11, 2001·British Journal of Pharmacology·A KawabataK Kawai
Nov 22, 2001·Proceedings of the National Academy of Sciences of the United States of America·S FiorucciG Cirino
Feb 19, 2002·The Journal of Physiology·John E CuffeChristoph Korbmacher
Mar 6, 2002·British Journal of Pharmacology·Naoyuki KawaoAtsufumi Kawabata
Apr 4, 2002·Neuroreport·Atsufumi KawabataHiroyuki Nishikawa
Jun 22, 2002·Gut·G BarbaraR Corinaldesi
Jul 18, 2002·Japanese Journal of Pharmacology·Naoyuki KawaoAtsufumi Kawabata
Nov 5, 2002·The American Journal of Pathology·Nicolas CenacNathalie Vergnolle
Jan 4, 2003·The Journal of Clinical Investigation·William R FerrellJunichi Kawagoe
Feb 21, 2004·The Journal of Pharmacology and Experimental Therapeutics·Atsufumi KawabataRobin Plevin
Mar 24, 2004·Journal of Pharmacological Sciences·Naoyuki KawaoAtsufumi Kawabata
May 7, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Yi DaiKoichi Noguchi
May 7, 2004·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Silvia AmadesiNigel W Bunnett
Citations
Apr 3, 2007·BMC Physiology·Ricardo SabanMarcia R Saban
Mar 1, 2011·Neuroscience·M MatsunamiA Kawabata
Apr 17, 2007·Life Sciences·Hiroyasu IshikuraAtsufumi Kawabata
Aug 20, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·R RókaL Bueno
Mar 28, 2008·Neurogastroenterology and Motility : the Official Journal of the European Gastrointestinal Motility Society·A P M KerckhoffsM Samsom
Jan 14, 2010·British Journal of Pharmacology·Robson CostaJoão B Calixto
Oct 16, 2008·Biochemical and Biophysical Research Communications·Yusuke TanakaAtsufumi Kawabata
Jan 24, 2015·Evidence-based Complementary and Alternative Medicine : ECAM·Shuping ChenJianliang Zhang
Mar 13, 2015·Frontiers in Psychiatry·Rachel D MoloneyJohn F Cryan
Nov 13, 2007·British Journal of Pharmacology·A KawabataF Sekiguchi
Feb 11, 2012·American Journal of Physiology. Gastrointestinal and Liver Physiology·Angèle P M KerckhoffsMelvin Samsom
Oct 18, 2012·Physiological Reviews·Gábor Petho, Peter W Reeh
Jan 7, 2017·World Journal of Gastroenterology : WJG·Hannah CeuleersBenedicte Y De Winter
Dec 19, 2018·Digestive Diseases and Sciences·Ying-Jie LiMin Jiang
Sep 1, 2006·Nihon yakurigaku zasshi. Folia pharmacologica Japonica·Atsufumi Kawabata
Dec 3, 2020·Frontiers in Psychiatry·Alison Accarie, Tim Vanuytsel
Jul 31, 2013·Journal of Medicinal Chemistry·Mei-Kwan YauDavid P Fairlie